Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer

NCT00101842 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Transitional Cell

Interventions

DRUG: Pemetrexed
DRUG: Gemcitabine
DRUG: Platinol

Sponsor

Eli Lilly and Company